Gene · 23705
Papers3,480
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,480
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of insulin-like growth factor 2 mRNA-binding protein 1 sensitizes colorectal cancer cells to chemotherapeutics. | FASEB Bioadv | 2022 | 36479210 | PubTator, text mining | PubMed |
| A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer. | Front Immunol | 2022 | 36466815 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type. | Aging Dis | 2022 | 36465169 | PubTator, text mining | PubMed |
| Surveying lncRNA-lncRNA cooperations reveals dominant effect on tumor immunity cross cancers. | Commun Biol | 2022 | 36463330 | PubTator, text mining | PubMed |
| In silico evaluation of flavonoids as potential inhibitors of SARS-CoV-2 main nonstructural proteins (Nsps)-amentoflavone as a multitarget candidate. | J Mol Model | 2022 | 36445575 | PubTator, text mining | PubMed |
| Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer. | Front Oncol | 2022 | 36439439 | PubTator, text mining | PubMed |
| Ascaris suum excretory/secretory products differentially modulate porcine dendritic cell subsets. | Front Immunol | 2022 | 36439124 | PubTator, text mining | PubMed |
| Human Lung Mast Cells: Therapeutic Implications in Asthma. | Int J Mol Sci | 2022 | 36430941 | PubTator, text mining | PubMed |
| Tissue-Specific Human Extracellular Matrix Scaffolds Promote Pancreatic Tumour Progression and Chemotherapy Resistance. | Cells | 2022 | 36429078 | PubTator, text mining | PubMed |
| Editorial: Identification of novel biomarkers for pancreatic and hepatocellular cancers. | Front Oncol | 2022 | 36425560 | PubTator, text mining | PubMed |
| Advances with metal oxide-based nanoparticles as MDR metastatic breast cancer therapeutics and diagnostics. | RSC Adv | 2022 | 36425155 | PubTator, text mining | PubMed |
| Serotype Distribution, Virulence Determinants and Antimicrobial Susceptibility of Streptococcus agalactiae Isolated from Young Infants | Pathogens | 2022 | 36422606 | PubTator, text mining | PubMed |
| Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma. | Biomolecules | 2022 | 36421707 | PubTator, text mining | PubMed |
| Manipulating polydispersity of lens β-crystallins using divalent cations demonstrates evidence of calcium regulation. | Proc Natl Acad Sci U S A | 2022 | 36417439 | PubTator, text mining | PubMed |
| Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding. | PLoS Comput Biol | 2022 | 36409737 | PubTator, text mining | PubMed |
| Alzheimer's disease alters the transcriptomic profile of natural killer cells at single-cell resolution. | Front Immunol | 2022 | 36405736 | PubTator, text mining | PubMed |
| Glucocorticoids unmask silent non-coding genetic risk variants for common diseases. | Nucleic Acids Res | 2022 | 36399508 | PubTator, text mining | PubMed |
| Knockdown of LINC01279 Suppresses Gastric Cancer Proliferation and Migration by Inhibiting PI3K/Akt/mTOR Signaling Pathway. | J Oncol | 2022 | 36397761 | PubTator, text mining | PubMed |
| Bioinformatics analysis of miRNAs in the neuroblastoma 11q-deleted region reveals a role of miR-548l in both 11q-deleted and MYCN amplified tumour cells. | Sci Rep | 2022 | 36396668 | PubTator, text mining | PubMed |
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. | Cancer Cell | 2022 | 36379208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23705/papers?page=26